BIS

Frequently Asked Questions on Migration to IS/IEC 62368-1:2023

Posted by: Hitesh Gupta July 27, 2026

7
Comments Off on Frequently Asked Questions on Migration to IS/IEC 62368-1:2023
27th July, 2026

Transition Facilitation (Quality Control) Order, 2026

Posted by: Hitesh Gupta July 3, 2026

7
Comments Off on Transition Facilitation (Quality Control) Order, 2026
3rd July, 2026

Safety of Household, Commercial and Similar Electrical Appliances (Quality Control) Order, 2026

Posted by: Hitesh Gupta April 13, 2026

7
Comments Off on Safety of Household, Commercial and Similar Electrical Appliances (Quality Control) Order, 2026
13th April, 2026

Withdrawal of Tin Ingot (Quality Control) Order, 2025

Posted by: Prabhas Chakraborty November 21, 2025

7
Comments Off on Withdrawal of Tin Ingot (Quality Control) Order, 2025
21st November, 2025

Machinery and Electrical Equipment Safety (Omnibus Technical Regulation) Second Amendment Order, 2025

Posted by: Prabhas Chakraborty November 21, 2025

7
Comments Off on Machinery and Electrical Equipment Safety (Omnibus Technical Regulation) Second Amendment Order, 2025
21st November, 2025

Tin Ingot (Quality Control) Amendment Order, 2025

Posted by: Prabhas Chakraborty October 9, 2025

7
Comments Off on Tin Ingot (Quality Control) Amendment Order, 2025
9th October, 2025

What's New 2?

Regulation/Guidelines

India as a Cosmetic Manufacturing Hub: CDSCO, BIS, and the Regulatory Enablers for Global Manufacturers

The Strategic Shift For most global Cosmetic brands, India's regulatory journey has begun with import registration — the COS-2 pathway explored throughout this series. But for a growing cohort of...

5th August, 2026

Regulation/Guidelines

Post-Market Surveillance Under Medical Device Rules, 2017

Regulatory approval is often treated as the finish line. In reality, for Medical Device and IVD manufacturers in India, it marks the start of an equally demanding obligation: Post-Market Surveillance...

4th August, 2026

Regulation/Guidelines

How to Sequence Global and India Market Entry for Medical Devices Without Creating Regulatory Rework

One of the most avoidable and expensive mistakes in Medical Device commercialisation is Regulatory rework — the process of going back to redo documentation, testing, or submissions because the original...

3rd August, 2026

Regulation/Guidelines

Blood and Plasma-Derived Product Approvals in India: Regulatory and Quality Expectations

Blood and Plasma-derived Medicinal products (PDMPs) — including immunoglobulins, albumin, clotting factors, and hyperimmune globulins — occupy a critical and highly regulated niche in India's healthcare system. These products are...